Company Filing History:
Years Active: 2022
Title: Emil Norell: Innovator in Radiotherapy Treatment Planning
Introduction
Emil Norell is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of radiotherapy, particularly in the area of treatment planning. His innovative approach has the potential to enhance the effectiveness of radiation therapy systems.
Latest Patents
Emil Norell holds a patent for "Methods for treatment planning" in the field of radiotherapy. This patent involves methods for dose or treatment planning for a radiation therapy system equipped with a collimator. The process includes determining shots to be delivered during treatment, with each shot associated with an isocenter and modeled by a spatial dose volume distribution of radiation. The shape of this spatial distribution depends on the specific collimator setting and the selected dose level. The method also includes selecting isocenter positions within a target in a predetermined angle range, evaluating each isocenter based on predetermined conditions, and selecting specific collimator and sector settings for each isocenter based on the evaluation. The steps are repeated until at least one stopping criterion is reached, resulting in a final set of isocenters used in treatment planning. Emil Norell has 1 patent to his name.
Career Highlights
Emil Norell is currently employed at Elekta, Inc., a company renowned for its innovative solutions in the field of radiation therapy. His work at Elekta has allowed him to apply his expertise in developing advanced treatment planning methods that improve patient outcomes.
Collaborations
Emil collaborates with talented professionals in his field, including Stella Riad and Håkan Nordström. Their combined efforts contribute to the advancement of radiotherapy technologies and methodologies.
Conclusion
Emil Norell's contributions to radiotherapy treatment planning exemplify the impact of innovation in healthcare. His work continues to pave the way for improved treatment options for patients undergoing radiation therapy.